Raymond James & Associates Ark Genomic Revolution ETF (De Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Raymond James & Associates holds 60,535 shares of ARKG stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,535
Previous 82,411
26.55%
Holding current value
$1.84 Million
Previous $1.94 Million
19.95%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ARKG
# of Institutions
278Shares Held
18.9MCall Options Held
3.97MPut Options Held
4.4M-
Jpmorgan Chase & CO New York, NY3.43MShares$104 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.18MShares$96.6 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.13MShares$64.5 Million0.0% of portfolio
-
Ubs Group Ag1.35MShares$41 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA1.09MShares$33 Million0.01% of portfolio